92 related articles for article (PubMed ID: 23689613)
1. Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains.
Perez-Cervera Y; Dehennaut V; Aquino Gil M; Guedri K; Solórzano Mata CJ; Olivier-Van Stichelen S; Michalski JC; Foulquier F; Lefebvre T
FASEB J; 2013 Sep; 27(9):3478-86. PubMed ID: 23689613
[TBL] [Abstract][Full Text] [Related]
2. o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells.
Song M; Kim HS; Park JM; Kim SH; Kim IH; Ryu SH; Suh PG
Cell Signal; 2008 Jan; 20(1):94-104. PubMed ID: 18029144
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
4. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
5. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
6. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol disrupts lipid rafts and impairs insulin signaling in SH-SY5Y cells.
Sánchez-Wandelmer J; Dávalos A; de la Peña G; Cano S; Giera M; Canfrán-Duque A; Bracher F; Martín-Hidalgo A; Fernández-Hernando C; Lasunción MA; Busto R
Neuroscience; 2010 Apr; 167(1):143-53. PubMed ID: 20123000
[TBL] [Abstract][Full Text] [Related]
8. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
9. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.
Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS
Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in cholesterol-induced neuronal insulin resistance.
Taghibiglou C; Bradley CA; Gaertner T; Li Y; Wang Y; Wang YT
Neuropharmacology; 2009 Sep; 57(3):268-76. PubMed ID: 19523477
[TBL] [Abstract][Full Text] [Related]
11. Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells.
Das S; Chakraborty S; Basu A
J Neurochem; 2010 Oct; 115(2):537-49. PubMed ID: 20722967
[TBL] [Abstract][Full Text] [Related]
12. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes.
Kabouridis PS; Janzen J; Magee AL; Ley SC
Eur J Immunol; 2000 Mar; 30(3):954-63. PubMed ID: 10741414
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor activation through its accumulation in lipid rafts by mild electrical stress.
Morino-Koga S; Yano S; Kondo T; Shimauchi Y; Matsuyama S; Okamoto Y; Suico MA; Koga T; Sato T; Shuto T; Arima H; Wada I; Araki E; Kai H
J Cell Physiol; 2013 Feb; 228(2):439-46. PubMed ID: 22740366
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of O-GlcNAcylation alleviates insulin signaling pathway impairment following arsenic exposure via suppressing the AMPK/mTOR-autophagy pathway.
Zhang W; Zeng S; Huang J; Tian X; Wu J; Guo L; Liang Y
Toxicol Lett; 2024 Jun; 397():67-78. PubMed ID: 38734222
[TBL] [Abstract][Full Text] [Related]
16. Sterol carrier protein-2 selectively alters lipid composition and cholesterol dynamics of caveolae/lipid raft vs nonraft domains in L-cell fibroblast plasma membranes.
Atshaves BP; Gallegos AM; McIntosh AL; Kier AB; Schroeder F
Biochemistry; 2003 Dec; 42(49):14583-98. PubMed ID: 14661971
[TBL] [Abstract][Full Text] [Related]
17. Defective insulin receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes.
Vainio S; Bykov I; Hermansson M; Jokitalo E; Somerharju P; Ikonen E
Biochem J; 2005 Nov; 391(Pt 3):465-72. PubMed ID: 15943586
[TBL] [Abstract][Full Text] [Related]
18. CD40 translocation to lipid rafts: signaling requirements and downstream biological events.
Nadiri A; Polyak MJ; Jundi M; Alturaihi H; Reyes-Moreno C; Hassan GS; Mourad W
Eur J Immunol; 2011 Aug; 41(8):2358-67. PubMed ID: 21567389
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of lipid rafts in human activated T cells.
Tani-ichi S; Maruyama K; Kondo N; Nagafuku M; Kabayama K; Inokuchi J; Shimada Y; Ohno-Iwashita Y; Yagita H; Kawano S; Kosugi A
Int Immunol; 2005 Jun; 17(6):749-58. PubMed ID: 15967787
[TBL] [Abstract][Full Text] [Related]
20. Involvement of lipid rafts in multiple signal transductions mediated by two isoforms of thromboxane A₂ receptor: dependency on receptor isoforms and downstream signaling types.
Goto S; Saito M; Obara Y; Moriya T; Nakahata N
Eur J Pharmacol; 2012 Oct; 693(1-3):15-24. PubMed ID: 22963705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
